• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The 2020 Taiwan Stroke Society guidelines for blood pressure control at the acute stage of ischemic stroke
J Formos Med Assoc. 2022 Aug 27:S0929-6646(22)00318-7. doi: 10.1016/j.jfma.2022.08.010. Online ahead of print.ABSTRACTThe 2020 Taiwan Stroke Society (TSS) guidelines for blood pressure (BP) control related to ischemic stroke update the 2015 TSS BP guidelines. The early management of acute ischemic stroke has evolved rapidly in the previous two decades. Since the publication of the previous version of the TSS BP guidelines, many studies have addressed BP management in ischemic stroke. Particularly, several successful endovascular thrombectomy (EVT) trials published in 2015 led to a new era of acute treatment for ischemic st...
Source: J Formos Med Assoc - August 30, 2022 Category: General Medicine Authors: Chun-Jen Lin Chih-Ping Chung Hao-Ming Cheng Chi-Hung Liu Li-Chi Hsu Nai-Fang Chi Sung-Chun Tang Jiunn-Tay Lee Helen L Po Jiann-Shing Jeng Tzung-Dau Wang I-Hui Lee Taiwan Stroke Society Guidelines Consensus Group Source Type: research

Detailed risks and characteristics of postepilepsy stroke in non-traumatic adult-onset epilepsy
CONCLUSION: Since the increased risk of stroke in epilepsy cohort peaked immediately after epilepsy diagnosis, early implementation of prevention strategies is considered.PMID:35484004 | DOI:10.1016/j.jfma.2022.04.003
Source: J Formos Med Assoc - April 28, 2022 Category: General Medicine Authors: Po-Yu Lin Chi-Hung Liu Yu-Ming Chang Chin-Wei Huang Hui-Chen Su Sheng-Hsiang Lin Pi-Shan Sung Source Type: research

2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke
J Formos Med Assoc. 2022 Apr 8:S0929-6646(22)00103-6. doi: 10.1016/j.jfma.2022.03.001. Online ahead of print.ABSTRACTThe previously published 2017 Taiwan Lipid Guidelines for High Risk Patients becomes the standard guidance of dyslipidemia management for patients with atherosclerotic cardiovascular disease (ASCVD) in Taiwan. New clinical trials of lipid lowering therapy were published successively after 2017. The study results changed the treatment concept of ASCVD. Therefore, an update focusing on the lipid treatment strategy for patients with ASCVD becomes necessary. In this focused update of the 2017 guideline, the trea...
Source: J Formos Med Assoc - April 12, 2022 Category: General Medicine Authors: Po-Sheng Chen Meng Lee Sung-Chun Tang Po-Hsun Huang Hung-I Yeh Charles Jia-Yin Hou I-Chang Hsieh Jiunn-Tay Lee Jiann-Shing Jeng Yi-Heng Li Source Type: research

Comparison of risk scores in predicting symptomatic intracerebral hemorrhage after endovascular thrombectomy
CONCLUSION: Among various risk scores, the TAG and SEDAN scores best predict SICH after EVT. Higher glucose level and unsuccessful recanalization, which are included in the TAG and SEDAN scores, are independent risk factors of SICH in the present cohort, highlighting their detrimental effects.PMID:34556379 | DOI:10.1016/j.jfma.2021.09.005
Source: J Formos Med Assoc - September 24, 2021 Category: General Medicine Authors: Chuan-Hsiu Fu Chih-Hao Chen Chun-Hsien Lin Chung-Wei Lee Meng Lee Sung-Chun Tang Jiann-Shing Jeng Source Type: research

Quality and safety of Telemedicine in acute ischemic stroke: Early experience in Taiwan
CONCLUSION: In the ED, consultation via the telestroke program provides equal quality to the original face-to-face consultation model to manage ischemic stroke.PMID:33994236 | DOI:10.1016/j.jfma.2021.04.024
Source: J Formos Med Assoc - May 17, 2021 Category: General Medicine Authors: Chun-Hsiang Lin Kwo-Whei Lee Ta-Cheng Chen Jian-Hui Lin Ke-Ru Liaw Pi-Ju Hsiao Wei-Ying Tsai Mu-Chien Sun Source Type: research

Diagnosis and Treatment for embolic stroke of undetermined source: Consensus statement from the Taiwan stroke society and Taiwan society of cardiology.
Abstract Cryptogenic stroke comprises about one-quarter of ischemic strokes with high recurrence rate; however, studies specifically investigating the features and treatment of this stroke subtype are rare. The concept of 'embolic stroke of undetermined source' (ESUS) may facilitate the development of a standardized approach to diagnose cryptogenic stroke and improve clinical trials. Since recent large randomized control trials failed to demonstrate a reduction in stroke recurrence with anticoagulants, anti-platelet agents remain the first-line treatment for ESUS patients. Nevertheless, patients with high risk of ...
Source: J Formos Med Assoc - June 9, 2020 Category: General Medicine Authors: Tsai LK, Lee IH, Chen YL, Chao TF, Chen YW, Po HL, Lien LM, Chu PH, Huang WC, Lin TH, Lin MT, Jeng JS, Hwang JJ Tags: J Formos Med Assoc Source Type: research

Pages: 1  2